NCT02010814 Characterization of a Prospective Cohort of Women With PCOS
| NCT ID | NCT02010814 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Odense University Hospital |
| Condition | Polycystic Ovary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2012-01-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2012-01-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. PCOS is characterized by increase levels of testosterone, unwanted hair growth, adiposity, irregular menstrual cycle, and infertility. PCOS is associated with diabetes mellitus and cardiovascular diseases. Women with PCOS are reported to have increased levels of stress hormones, which may be associated with decreased quality of life. Increased testosterone levels in women may decrease the risk of osteoporosis. The aim of the present study is to measure levels of stress hormones in urine and describe quality of life using questionnaires. In addition we aim to characterize body composition and bone architecture using DXA and ExtremeCT. As part of the project, a Biobank with fasting blood samples from participants is established.
Eligibility Criteria
Inclusion Criteria: * PCOS Exclusion Criteria: * pregnancy
Contact & Investigator
Dorte Glintborg, MD PhD
PRINCIPAL INVESTIGATOR
Department of Endocrinology, Odense University Hospital
Frequently Asked Questions
Who can join the NCT02010814 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Polycystic Ovary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02010814 currently recruiting?
Yes, NCT02010814 is actively recruiting participants. Contact the research team at marianne.andersen@rsyd.dk for enrollment information.
Where is the NCT02010814 trial being conducted?
This trial is being conducted at Odense, Denmark.
Who is sponsoring the NCT02010814 clinical trial?
NCT02010814 is sponsored by Odense University Hospital. The principal investigator is Dorte Glintborg, MD PhD at Department of Endocrinology, Odense University Hospital. The trial plans to enroll 500 participants.